Division of Pre-Clinical Innovation
E93882
The Division of Pre-Clinical Innovation is a research branch of the National Center for Advancing Translational Sciences focused on developing and applying innovative preclinical methods to accelerate the translation of scientific discoveries into new therapies.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Division of Pre-Clinical Innovation canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T789406 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Division of Pre-Clinical Innovation Context triple: [National Center for Advancing Translational Sciences, hasPart, Division of Pre-Clinical Innovation]
-
A.
Division of Extramural Research
The Division of Extramural Research is a branch of the National Human Genome Research Institute that oversees and funds genome-related research conducted outside the institute.
-
B.
Division of Intramural Research
The Division of Intramural Research is the National Heart, Lung, and Blood Institute’s in-house research arm that conducts basic, translational, and clinical studies on cardiovascular, pulmonary, and blood-related diseases.
-
C.
Center for Health and Biosciences
The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
-
D.
Bioengineering Division
The Bioengineering Division is a specialized group within the American Society of Mechanical Engineers that focuses on the application of mechanical engineering principles to biological and medical systems.
-
E.
Department of Biomedical Engineering
The Department of Biomedical Engineering is an academic unit at McGill University that focuses on applying engineering principles and technologies to advance medical research, healthcare, and human health.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Division of Pre-Clinical Innovation Target entity description: The Division of Pre-Clinical Innovation is a research branch of the National Center for Advancing Translational Sciences focused on developing and applying innovative preclinical methods to accelerate the translation of scientific discoveries into new therapies.
-
A.
Division of Extramural Research
The Division of Extramural Research is a branch of the National Human Genome Research Institute that oversees and funds genome-related research conducted outside the institute.
-
B.
Division of Intramural Research
The Division of Intramural Research is the National Heart, Lung, and Blood Institute’s in-house research arm that conducts basic, translational, and clinical studies on cardiovascular, pulmonary, and blood-related diseases.
-
C.
Center for Health and Biosciences
The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
-
D.
Bioengineering Division
The Bioengineering Division is a specialized group within the American Society of Mechanical Engineers that focuses on the application of mechanical engineering principles to biological and medical systems.
-
E.
Department of Biomedical Engineering
The Department of Biomedical Engineering is an academic unit at McGill University that focuses on applying engineering principles and technologies to advance medical research, healthcare, and human health.
- F. None of above. chosen
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
organizational unit
ⓘ
research division ⓘ |
| abbreviation | DPI ⓘ |
| activity |
conducts collaborative preclinical research projects
ⓘ
develops novel screening technologies ⓘ develops predictive preclinical models ⓘ optimizes lead compounds for therapeutic use ⓘ supports translational projects across disease areas ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| employer | National Center for Advancing Translational Sciences staff ⓘ |
| employs |
research staff
ⓘ
scientists ⓘ technical staff ⓘ |
| field |
assay development
ⓘ
biomarker discovery ⓘ chemical biology ⓘ drug discovery ⓘ high-throughput screening ⓘ preclinical research ⓘ preclinical therapeutics ⓘ rare diseases research ⓘ repurposing of existing drugs ⓘ therapeutic development ⓘ toxicology ⓘ translational science ⓘ |
| focus |
early-stage therapeutic development
ⓘ
innovative preclinical methods ⓘ partnerships with academic investigators ⓘ partnerships with industry ⓘ partnerships with patient advocacy groups ⓘ platform technologies for drug discovery ⓘ translation of basic scientific discoveries into potential therapies ⓘ |
| fundingSource |
National Institutes of Health budget
ⓘ
United States government ⓘ
surface form:
U.S. federal government
|
| goal |
to improve the success rate of candidate therapeutics entering clinical trials
ⓘ
to reduce the time and cost of therapeutic development ⓘ |
| jurisdiction |
United States government
ⓘ
surface form:
United States federal government
|
| languageOfWork | English ⓘ |
| locatedIn |
Maryland
ⓘ
Rockville, Maryland ⓘ |
| mission | to develop and apply innovative preclinical methods to accelerate the translation of scientific discoveries into new therapies ⓘ |
| parentOrganization |
National Center for Advancing Translational Sciences
ⓘ
National Institutes of Health ⓘ |
| partOf |
National Center for Advancing Translational Sciences
ⓘ
surface form:
NCATS
National Center for Advancing Translational Sciences ⓘ National Institutes of Health ⓘ |
| sector | biomedical research ⓘ |
| website | https://ncats.nih.gov/about/organization/dpi ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Division of Pre-Clinical Innovation Description of subject: The Division of Pre-Clinical Innovation is a research branch of the National Center for Advancing Translational Sciences focused on developing and applying innovative preclinical methods to accelerate the translation of scientific discoveries into new therapies.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.